Arrowstreet Capital, Limited Partnership Orchard Therapeutics PLC Transaction History

Arrowstreet Capital, Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.11 - $6.45 $76,035 - $119,325	-18,500 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$5.75 - $11.99 $106,375 - $221,815	18,500 New	18,500 $111,000
Q1 2020 May 15, 2020	SELL	$5.65 - $15.71 $892,038 - $2.48 Million	-157,883 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$10.15 - $15.58 $155,010 - $237,937	-15,272 Reduced 8.82%	157,883 $2.17 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $1.58 Million - $2.22 Million	132,905 Added 330.2%	173,155 $2.06 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $531,300 - $830,357	40,250 New	40,250 $563,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.